Browsing by Author García Pagán, Juan Carlos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 30  next >
Issue DateTitleAuthor(s)
15-Jan-2014A histologic scoring system for prognosis of patients with Alcoholic hepatitisAltamirano, José; Miquel Morera, Rosa; Katoonizadeh, Aezam; Abraldes, Juan G.; Duarte Rojo, Andrés; Louvet, Alexandre; Augustin, Salvador; Mookerjee, Rajeshwar P.; Michelena, Javier; Smyrk, Thomas C.; Buob, David; Leteurtre, Emmanuelle; Rincón, Diego; Ruiz, Pablo; García Pagán, Juan Carlos; Guerrero Marquez, Carmen; Jones, Patricia D.; Barritt, A.S 4th.; Arroyo, Vicente; Bruguera i Cortada, Miquel, 1942-; Bañares, Rafael; Ginès i Gibert, Pere; Caballeria, Juan; Roskams, Tania; Nevens, Frederik; Jalan, Rajiv; Mathurin, Philippe; Shah, Vijay H.; Bataller, Ramón
11-Jun-2015A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.Vannucchi, Alessandro M.; Kantarjian, Hagop M.; Kiladjian, Jean-Jacques; Gotlib, Jason; Cervantes Requena, F.; Mesa, Ruben A.; Sarlis, Nicholas J.; Peng, Wei; Sandor, Victor; Gopalakrishna, Prashanth; Hmissi, Abdel; Stalbovskaya, Viktoriya; Gupta, Vikas; Harrison, Claire; Verstovsek, Srdan; García Pagán, Juan Carlos
2003Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Transjugular intrahepatic portosystemic shuntBellis, L.; Moitinho, E.; Abraldes, Juan G.; Graupera i Garcia-Milà, Mariona; García Pagán, Juan Carlos; Rodés, J.; Bosch i Genover, Jaume
Aug-2014Anticoagulación de la trombosis venosa portal en la cirrosisSeijo Ríos, Susana; García Pagán, Juan Carlos
2002Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?Burroughs, Andrew K.; Groszmann, Roberto J.; Bosch i Genover, Jaume; Grace, N.; Garcia-Tsao, G.; Patch, D.; García Pagán, Juan Carlos; Dagher, L.
27-May-2013Avances en el diagnóstico, etiopatogenia y pronóstico de la hipertensión portal no cirróticaSeijo Ríos, Susana
2000CO2 wedged hepatic venography in the evaluation of portal hypertensionDebernardi-Venon, W.; Bandi, J. C.; García Pagán, Juan Carlos; Moitinho, E.; Andreu, V.; Real, M.; Escorsell i Mañosa, M. Àngels; Montanyá, X.; Bosch i Genover, Jaume
24-Jun-2010Early use of TIPS in patients with cirrhosis and variceal bleedingGarcía Pagán, Juan Carlos; Caca, Karel; Bureau, Christophe; Laleman, Wim; Appenrodt, Beate; Luca, Angelo; Abraldes, Juan G.; Nevens, Frederik; Vinel, Jean Pierre; Mössner, Joachim; Bosch i Genover, Jaume
8-Mar-2013Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertensionBerzigotti, Annalisa; Gottardi, Andrea De; Vukotic, Ranka; Siramolpiwat, Sith; Abraldes, Juan G.; García Pagán, Juan Carlos; Bosch i Genover, Jaume
Apr-2017Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet studyBerzigotti, Annalisa; Albillos, Agustín; Villanueva, Candid; Genescá, Joan; Ardevol, Alba; Augustín, Salvador; Calleja, Jose Luis; Bañares, Rafael; García Pagán, Juan Carlos; Mesonero, Francisco; Bosch i Genover, Jaume; Ciberehd SportDiet Collaborative Group
24-Feb-2016Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapyHide Alférez, Diana; Ortega Ribera, Martí; García Pagán, Juan Carlos; Peralta Uroz, Carmen; Bosch i Genover, Jaume; Gracia-Sancho, Jorge
8-Oct-2012Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosisBerzigotti, Annalisa; Seijo Ríos, Susana; Arena, Umberto; Abraldes, Juan G.; Vizzutti, Francesco; García Pagán, Juan Carlos; Pinzani, Massimo; Bosch i Genover, Jaume
12-Mar-2009Incidence, prevalence and clinical significance of abnormal hematological indices in compensated cirrhosisQamar, A. A.; Grace, N. D.; Groszmann, R. J.; Garcia Tsao, Guadalupe; Bosch i Genover, Jaume; Burroughs, Andrew K.; Ripoll, C.; Maurer, R.; Planas, R.; Escorsell, A.; García Pagán, Juan Carlos; Patch, D.; Matloff, D. S.; Makuch, R.; Rendon, G.
12-Jun-2017Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studiesMesquita, Fernanda Cristina de; Guixé Muntet, Sergi; Fernández Iglesias, Anabel; Maeso Díaz, Raquel; Vila, Sergi; Hide Alférez, Diana; Ortega Ribera, Martí; Rosa López, José Luis; García Pagán, Juan Carlos; Bosch i Genover, Jaume; Oliveira, Jarbas Rodrigues de; Gracia-Sancho, Jorge
30-Jun-2016Mecanismes involucrats en la regulació de la resistència vascular intrahepàtica en la cirrosi: paper dels anticoagulants i antioxidantsVilaseca Barceló, Marina
19-Mar-2009Mecanismes involucrats en la regulació del to vascular hepàtic en la cirrosi: Paper de l'estrès oxidatiu i biodisponibilitat d'òxid nítricLaviña Siemsen, Bárbara
16-Dec-2013Mecanismes involucrats en la regulació del to vascular hepàtic en la cirrosi: Paper dels antioxidants en la biodisponibilitat de l’òxid nítricDiví Oriol, Marta
7-Jan-2013Mecanismes involucrats en la regulació del to vascular hepàtic en la cirrosi: Paper dels prostanoids vasoconstrictors i biodisponibilitat d'òxid nítricRosado Mateo, Eugenio
21-Dec-2007Mecanismes involucrats en la regulació del to vascular hepàtic en la cirrosi: Paper dels prostanoids vasoconstrictors i de l'estrès oxidatiuGracia-Sancho, Jorge
2007NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive ratsAngermayr, Bernhard; Fernández Lobato, Mercedes; Mejías, Marc; Gracia-Sancho, Jorge; García Pagán, Juan Carlos; Bosch i Genover, Jaume